Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

23 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Horizontal DNA and mRNA transfer between donor and recipient cells after allogeneic hematopoietic cell transplantation?
Waterhouse M, Themeli M, Metaxas Y, Lagadinou ED, Finke J, Spyridonidis A. Waterhouse M, et al. Front Biosci (Landmark Ed). 2009 Jan 1;14:2704-13. doi: 10.2741/3407. Front Biosci (Landmark Ed). 2009. PMID: 19273229 Review.
Identification of a novel HLA-G+ regulatory population in blood: expansion after allogeneic transplantation and de novo HLA-G expression at graft-versus-host disease sites.
Lazana I, Zoudiari A, Kokkinou D, Themeli M, Liga M, Papadaki H, Papachristou D, Spyridonidis A. Lazana I, et al. Haematologica. 2012 Sep;97(9):1338-47. doi: 10.3324/haematol.2011.055871. Epub 2012 Mar 14. Haematologica. 2012. PMID: 22419574 Free PMC article.
Horizontal DNA transfer from donor to host cells as an alternative mechanism of epithelial chimerism after allogeneic hematopoietic cell transplantation.
Waterhouse M, Themeli M, Bertz H, Zoumbos N, Finke J, Spyridonidis A. Waterhouse M, et al. Biol Blood Marrow Transplant. 2011 Mar;17(3):319-29. doi: 10.1016/j.bbmt.2010.09.001. Epub 2010 Sep 15. Biol Blood Marrow Transplant. 2011. PMID: 20837151
Alloreactive microenvironment after human hematopoietic cell transplantation induces genomic alterations in epithelium through an ROS-mediated mechanism: in vivo and in vitro study and implications to secondary neoplasia.
Themeli M, Petrikkos L, Waterhouse M, Bertz H, Lagadinou E, Zoumbos N, Finke J, Spyridonidis A. Themeli M, et al. Leukemia. 2010 Mar;24(3):536-43. doi: 10.1038/leu.2009.284. Epub 2010 Jan 14. Leukemia. 2010. PMID: 20072151
Pre-clinical evaluation of CD38 chimeric antigen receptor engineered T cells for the treatment of multiple myeloma.
Drent E, Groen RW, Noort WA, Themeli M, Lammerts van Bueren JJ, Parren PW, Kuball J, Sebestyen Z, Yuan H, de Bruijn J, van de Donk NW, Martens AC, Lokhorst HM, Mutis T. Drent E, et al. Haematologica. 2016 May;101(5):616-25. doi: 10.3324/haematol.2015.137620. Epub 2016 Feb 8. Haematologica. 2016. PMID: 26858358 Free PMC article.
Pharmacokinetics and clinical activity of very low-dose alemtuzumab in transplantation for acute leukemia.
Spyridonidis A, Liga M, Triantafyllou E, Themeli M, Marangos M, Karakantza M, Zoumbos N. Spyridonidis A, et al. Bone Marrow Transplant. 2011 Oct;46(10):1363-8. doi: 10.1038/bmt.2010.308. Epub 2010 Dec 20. Bone Marrow Transplant. 2011. PMID: 21170091 Free PMC article. Clinical Trial.
New cell sources for T cell engineering and adoptive immunotherapy.
Themeli M, Rivière I, Sadelain M. Themeli M, et al. Cell Stem Cell. 2015 Apr 2;16(4):357-66. doi: 10.1016/j.stem.2015.03.011. Cell Stem Cell. 2015. PMID: 25842976 Free PMC article. Review.
Generation of tumor-targeted human T lymphocytes from induced pluripotent stem cells for cancer therapy.
Themeli M, Kloss CC, Ciriello G, Fedorov VD, Perna F, Gonen M, Sadelain M. Themeli M, et al. Nat Biotechnol. 2013 Oct;31(10):928-33. doi: 10.1038/nbt.2678. Epub 2013 Aug 11. Nat Biotechnol. 2013. PMID: 23934177 Free PMC article.
23 results
Jump to page
Feedback